(95 days)
Not Found
Not Found
No
The summary does not mention AI, ML, or any related terms, and the device description focuses on bio-Impedance Cardiography, a traditional physiological monitoring technique.
No
The device is described as a monitoring device, not one that provides therapy or treatment.
Yes
The device monitors and displays Cardiac Output, which is a physiological parameter used to assess a patient's health status, indicating its use in diagnosing or contributing to the diagnosis of medical conditions.
No
The device description explicitly states it is a "portable, non-invasive Cardiac Output monitoring device based on bio-Impedance Cardiography," which implies the use of hardware components (electrodes, sensors, etc.) to acquire bio-impedance data, not just software processing.
Based on the provided information, the Cheetah NICOM system is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Cheetah NICOM system description: The description clearly states that the Cheetah NICOM system is a non-invasive device that monitors Cardiac Output based on bio-Impedance Cardiography. This means it measures physiological signals from the body's surface without taking samples.
Therefore, since it does not involve testing samples taken from the body, it does not fit the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Cheetah NICOM system is a portable, non-invasive Cardiac Output monitoring device based on bio-Impedance Cardiography. The Cheetah NICOM system is intended to monitor and display a patient's Cardiac Output in units of [Ltr/Min].
Product codes
DXG
Device Description
NICOM - A NON-INVASIVE CARDIAC OUTPUT MONITOR
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1435 Single-function, preprogrammed diagnostic computer.
(a)
Identification. A single-function, preprogrammed diagnostic computer is a hard-wired computer that calculates a specific physiological or blood-flow parameter based on information obtained from one or more electrodes, transducers, or measuring devices.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 1 2 2004
Cheetah Medical, Inc. c/o Mr. Benny Arazy Arazy Group Mizpe Aviv, Industrial Park 13 M. P. Misgav 20187 ISRAEL
Re: K042144
Trade Name: EnSite System: Cheetah NICOM System Regulation Number: 21 CFR 870.1435 Regulation Name: Single-Function Pre-Programmable Diagnostic Computer Regulatory Class: Class II (two) Product Code: DXG Dated: October 29, 2004 Received: November 2, 2004
Dear Mr. Arazy:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your becamed the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the endrosale) to tegains and the Medical Device Amendments, or to connineres proct to May 20, 1978, are excordance with the provisions of the Federal Food, Drug, de vices that have been received in asse approval of a premarket approval application (PMA). and Cosmetic Act (110) that to hot requesubject to the general controls provisions of the Act. The r ou may, merelove, manel of the Act include requirements for annual registration, listing of general controls provisions of use tice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it rr your device is elaboriou (oor as controls. Existing major regulations affecting your device can may or subject to outer to out Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Mr. Benny Arazy
Please be advised that FDA's issuance of a substantial equivalence determination does not mean r that FDA has made a determination that your device complies with other requirements of the Act that I Dr has made a corel meallations administered by other Federal agencies. You must or any I catales and the Act's requirements, including, but not limited to: registration and listing (21 comply with an the 110 % 21 CFR Part 801); good manufacturing practice requirements as set OI It in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic form in the qualis) by bections (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation of to begin marketing your device as described in your Section 510(k) I mis lotter with and h your e FDA finding of substantial equivalence of your device to a legally promative notineansmy - results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please if you desire of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Blymmar for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known): K042144
Device Name: NICOM - A NON-INVASIVE CARDIAC OUTPUT MONITOR
Indications For Use:
The Cheetah NICOM system is a portable, non-invasive Cardiac Output monitoring device based on bio-Impedance Cardiography. The Cheetah NICOM system is intended to monitor and display a patient's Cardiac Output in units of [Ltr/Min].
Dr Hanan Keren
Chief Executive Officer (Name & Signature)
10 November 2004 Date
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
P. Zimmerman
.on sign-Off
Cardiovascular Devices
510(k) number K042144
Page 1 of 1